Non-Selective Melanocortin Receptor Agonist
Melanotan II (MT-2) is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). It functions as a non-selective agonist of the melanocortin receptors (MC1R, MC3R, MC4R, and MC5R). By stimulating these diverse receptor pathways, MT-2 promotes rapid melanogenesis (skin pigmentation) independently of extensive UV exposure, while simultaneously inducing significant systemic effects, most notably profound libido enhancement and appetite suppression. Its broad receptor affinity makes it a highly studied compound in dermatological defense, sexual dysfunction, and metabolic regulation research.
Rapid onset of receptor binding. Subjects typically exhibit acute, transient side effects such as facial flushing, mild nausea, and spontaneous arousal (MC4R activation). Appetite suppression begins immediately.
| Compound | Primary Mechanism | Key Benefit | Admin. |
|---|---|---|---|
| Melanotan II | Non-selective MC Agonist | Rapid pigmentation + strong libido enhancement | SubQ |
| Melanotan I | Selective MC1R Agonist | Pigmentation only (minimal systemic side effects) | SubQ |
| PT-141 | Selective MC4R Agonist | Libido enhancement only (no pigmentation) | SubQ |
| KPV | Alpha-MSH Fragment | Anti-inflammatory only (no pigmentation) | SubQ |
Because MT-2 is a non-selective agonist, it crosses the blood-brain barrier and binds to multiple melanocortin receptors throughout the body, causing a cascade of distinct physiological changes.
Binds to MC1R in melanocytes, stimulating the production and release of eumelanin (dark pigment). This process occurs naturally even without UV light, but is heavily accelerated by minor UV exposure.
Crosses into the central nervous system to bind with MC4R. This triggers a neurological (rather than vascular) pathway that induces arousal and spontaneous erections, independent of cardiovascular state.
Interaction with these receptors contributes to significant appetite suppression and slight alterations in lipid metabolism and exocrine gland function.
Approximately 1 to 2 hours in plasma, but physiological effects (like melanin production) cascade over days to weeks.
High via subcutaneous injection. Its cyclic structure makes it significantly more stable and resistant to enzymatic degradation than natural α-MSH.
Cleared primarily via renal excretion following systemic receptor binding and degradation.
Non-selective: MC1R, MC3R, MC4R, and MC5R.
MT-2 was originally developed to induce protective pigmentation against skin cancer, but its potent secondary effects led to divergent research paths.
Explores how synthetic α-MSH analogs upregulate melanin to defend against UV-induced damage.
NEUROLOGYA deep dive into how MT-2 bypasses vascular systems to induce arousal via the brain.
METABOLISMReviews the metabolic impact of MT-2 on energy homeostasis and satiety signaling.
Explore research-use products associated with this compound profile, including available formats, related blends, and supporting lab documentation where available.
Deeper research-focused questions about Melanotan II, alpha-MSH analogue research, melanocortin receptors, MC1R pigmentation pathways, MC3R/MC4R signaling models, storage, and batch documentation.
Melanotan II, also written as Melanotan-2 or MT-II, is a synthetic cyclic peptide commonly discussed as an alpha-melanocyte-stimulating hormone analogue. In research contexts, it is studied in relation to melanocortin receptor signaling, MC1R-associated pigmentation pathways, MC3R and MC4R signaling models, melanocyte biology, and broader melanocortin-system research. On this site, Melanotan II is positioned strictly as a laboratory research reference compound.
Alpha-MSH is an endogenous melanocortin peptide involved in melanocyte signaling and pigmentation biology. Melanotan II is a synthetic analogue developed for research into melanocortin receptor pathways. Because of that relationship, Melanotan II is frequently referenced in educational materials focused on melanocortin-system biology, MC1R-mediated pigmentation models, and receptor signaling across the broader melanocortin family.
Melanotan II is commonly discussed as a non-selective melanocortin receptor agonist in research contexts. The receptor categories most often referenced include MC1R, MC3R, MC4R, and MC5R. MC1R is strongly associated with melanocyte and pigmentation biology, while MC3R and MC4R are often discussed in central nervous system, appetite-signaling, neuroendocrine, and behavioral research models. The non-selective receptor profile is one of the main differences between Melanotan II and more MC1R-focused compounds.
Melanotan II is studied in pigmentation research because melanocortin signaling is closely connected to melanocyte activity, melanin biology, and MC1R-mediated pathways. Research discussions may include eumelanin-related endpoints, melanocyte signaling, ultraviolet exposure models, pigmentation-pathway activity, and melanocortin receptor biology. This makes Melanotan II part of a very different research category than repair peptides, metabolic peptides, or growth hormone secretagogue compounds.
Melanotan II and Melanotan-1 are both commonly discussed within alpha-MSH and melanocortin research, but they are not the same compound. Melanotan-1 is generally positioned closer to MC1R-focused pigmentation and photoprotection-related research, while Melanotan II is typically discussed as a broader, non-selective melanocortin receptor agonist with MC1R, MC3R, MC4R, and MC5R pathway relevance. For SEO and internal linking, these should remain separate resource pages because the receptor profiles and research angles are different.
MC4R is often discussed in Melanotan II research because the melanocortin-4 receptor is involved in central signaling models, including appetite-signaling, neuroendocrine, and behavioral pathway research. This does not mean Melanotan II products are intended for weight management, sexual function, or human use. It simply reflects that Melanotan II is commonly studied as a broader melanocortin-system research compound rather than a purely MC1R-selective pigmentation reference.
Melanotan II, PT-141, and Bremelanotide are often discussed within the broader melanocortin-receptor research family, but they should not be treated as interchangeable products. PT-141 and Bremelanotide are generally discussed around MC3R and MC4R pathway research, while Melanotan II is commonly positioned as a broader melanocortin receptor agonist that also includes MC1R pigmentation-pathway relevance. A research-use Melanotan II product should not be confused with any regulated pharmaceutical product or clinical protocol.
Melanotan II research discussions may involve endpoints related to MC1R activation, melanocyte signaling, eumelanin synthesis, pigmentation pathway activity, melanocortin receptor binding, MC3R and MC4R pathway models, appetite-signaling research, and neuroendocrine pathway analysis. The exact endpoints depend on the model, study design, receptor focus, and analytical methods being used.
No. Melanotan II is generally categorized around melanocortin receptor signaling and alpha-MSH analogue research. BPC-157 and TB-500 are more commonly discussed in tissue-support, repair-associated, cell-migration, and extracellular matrix research models. Retatrutide is typically positioned around GLP-1, GIP, glucagon, and metabolic pathway research. Melanotan II belongs in a separate research category focused on melanocortin biology, pigmentation pathways, and receptor signaling.
No. Melanotan II should not be presented as an approved tanning product, cosmetic product, medical treatment, or self-administered compound. This resource page is written only for research-reference and educational purposes. Products listed on Symbiotic Pharmaceuticals are positioned for laboratory research and analytical reference use only, not for tanning, cosmetic use, human use, or therapeutic application.
Storage requirements can vary by product format, batch, and label instructions. For research handling, follow the product label and applicable laboratory storage standards. In general, research peptides should be protected from unnecessary heat, light, moisture, and repeated temperature changes because these conditions may affect long-term stability and handling quality.
Available certificates of analysis and batch documentation can be reviewed through the Lab Results / COA page. Documentation availability may vary by product and inventory lot. Where available, batch documentation may include product identification, purity-focused testing references, and supporting analytical documentation.
Yes. Melanotan II products listed on Symbiotic Pharmaceuticals are intended for laboratory research and analytical reference use only. They are not intended for human consumption, animal consumption, diagnostic use, therapeutic use, cosmetic tanning use, sexual function use, weight management use, or self-administration. Any discussion on this page is provided for educational and research-reference purposes only.
The information provided in this resource hub is for educational and informational purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease.
